OptimizeRx Corporation (NASDAQ:OPRX) Q4 2025 Earnings Call Transcript March 5, 2026
OptimizeRx Corporation beats earnings expectations. Reported EPS is $0.51, expectations were $0.23.
Operator: Good afternoon, everyone, and thank you for joining OptimizeRx’ Fourth Quarter and Fiscal 2025 Earnings Conference Call. With us today is Chief Executive Officer, Steve Silvestro. He is joined by Chief Financial and Strategic Officer, Ed Stelmakh; Chief Legal and Administrative Officer, Marion...
